Meet Katherine: our newest board member
|
Katherine O'Brien is our newest MBCN board member and will serve as Secretary and Public Relations Chair.
She was diagnosed with a small volume of bone mets in 2009 at the age of 43. Meeting Joani Gudeman and Shirley Mertz at a Chicago seminar for people with breast cancer inspired her to attend MBCN's annual conference in 2010.
After her metastatic breast cancer diagnosis, she realized very few media accounts featured people living with a Stage IV diagnosis. She was determined to change that--she wrote many letters to the editor and frequently offered feedback to online stories. The late Ellen Moskowitz, then MBCN's President, read one of Katherine's letters and invited her to volunteer with the group.
|
Expanded study on Avastin
|
You may remember that Genentech and 23andMe, a genetics company, have partnered on an investigative study of Avastin (bevacizumab), called the InVite Study. The guidelines and recruitment standards have recently been expanded to include cancers other than breast cancer and to include those who may have received Avastin during 2012.
Please check out the updates HERE to see if you qualify or can recommend this important study to a friend. |
New brochure available:
Guide for the Newly Diagnosed
|
 MBCN collaborated with LBBC (Living Beyond Breast Cancer) to produce this new, in depth, 52 page guide for the newly diagnosed.
The brochure covers topics including diagnosis, treatment options and their side effects, clinical trials, and complementary therapies to relieve stress and anxiety.
Learn how to talk effectively about your concerns with your healthcare providers and with the people closest to you. Understand your diagnosis to play an active role in your treatment.
To ORDER click HERE . (The first 9 copies are FREE. Bulk orders over 10 copies have a modest pricing schedule.)
PLEASE ORDER SOME COPIES AND TAKE THEM TO YOUR ONCOLOGIST ON YOUR NEXT APPOINTMENT!
|
A Valentine for your Caregiver
|
Click and raise $ for metastatic breast cancer
|
Please help us continue to spread the word: For every new video upload, view, comment or share of the Faces of MBC Video Wall, Genentech will donate $1 to MBC initiatives and programs (up to $20,000). |
Breast Cancer Research Update
|
 MBCN represented the metastatic community at this recent Washington DC Summit. We wanted to share with you the opening remarks of NBCC's Laura Nikolaides:
|
Meet a Metastatic Researcher
|
 University of Maryland School of Medicine research team, led by Stuart S. Martin, PhD, is pursuing interesting research on The Role of Microtentacles in Breast Cancer. View this short, fascinating video
from 2009. Dr. Martin's team is continuing these studies and has published some findings in the journal Oncogene.
|
